GIPR and coronary artery disorder: We also performed a two-sample Mendelian randomisation (2SMR) analysis using the GIPR variant rs1800437 previously associated with features of the metabolic syndrome and CVD [11] as an instrumental variable to study the effect of increased GIP levels on coronary artery disease (CAD) and myocardial infarction.